The Enterprise Value as of November 2024 (TTM) for BeyondSpring Inc. (BYSI) is 77.93M

According to BeyondSpring Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 77.93M. This represents a change of 11.95% compared to the average of 69.61M of the last 4 quarters.

BeyondSpring Inc. (BYSI) Historical Enterprise Value (quarterly & annually)

How has BYSI Enterprise Value performed in the past?

The mean historical Enterprise Value of BeyondSpring Inc. over the last ten years is 258.95M. The current 77.93M Enterprise Value has changed 2.91% with respect to the historical average. Over the past ten years (40 quarters), BYSI's Enterprise Value was at its highest in in the December 2021 quarter at 176.74B. The Enterprise Value was at its lowest in in the June 2015 quarter at 0.

BeyondSpring Inc. (BYSI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of BeyondSpring Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BeyondSpring Inc. (BYSI) Average Enterprise Value

How has BYSI Enterprise Value performed in the past?

The current Enterprise Value of BeyondSpring Inc. (BYSI) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

BeyondSpring Inc. (BYSI) Enterprise Value vs. Peers

How is BYSI’s Enterprise Value compared to its peers?

BeyondSpring Inc.’s Enterprise Value is greater than Surrozen, Inc. (2.49M), less than Armata Pharmaceuticals, Inc. (204.77M), greater than Pasithea Therapeutics Corp. (-4187996.00), greater than Oncternal Therapeutics, Inc. (-1766718.00), greater than Aditxt, Inc. (12.23M), less than scPharmaceuticals Inc. (204.48M), less than Milestone Pharmaceuticals Inc. (118.83M), less than Oncolytics Biotech Inc. (100.69M), less than Seres Therapeutics, Inc. (278.81M), less than aTyr Pharma, Inc. (138.44M), greater than Kineta, Inc. (6.78M), less than Candel Therapeutics, Inc. (163.63M), greater than MiNK Therapeutics, Inc. (23.92M), greater than Forte Biosciences, Inc. (-3195101.00), greater than AlloVir, Inc. (6.59M), less than Ocuphire Pharma, Inc. (0), greater than Reviva Pharmaceuticals Holdings, Inc. (-9671816.00), greater than Protalix BioTherapeutics, Inc. (28.64M), less than EyePoint Pharmaceuticals, Inc. (96.89M), less than SELLAS Life Sciences Group, Inc. (707.60M), greater than null (66.71M),

Build a custom stock screener for BeyondSpring Inc. (BYSI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BeyondSpring Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BeyondSpring Inc. (BYSI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BeyondSpring Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.